Humanized antibody molecules to CD138 and uses thereof
US12338291B2 · kind B2 · utility
0Cited by
17References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2020 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Mar 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Humanized antibody molecules that specifically bind to CD138 are disclosed. The humanized antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as multiple myeloma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.